Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Hourigan, CS"'
Autor:
Heuser, M, Freeman, Sd, Ossenkoppele, Gj, Buccisano, F, Hourigan, Cs, Ngai, Ll, Tettero, Jm, Bachas, C, Baer, C, Béné, Mc, Buecklein, V, Czyz, A, Denys, B, Dillon, R, Feuring-Buske, M, Guzman, Ml, Haferlach, T, Han, L, Herzig, Jk, Jorgensen, Jl, Kern, W, Konopleva, My, Lacombe, F, Libura, M, Majchrzak, A, Maurillo, L, Ofran, Y, Philippé, J, Plesa, A, Preudhomme, C, Ravandi, F, Roumier, C, Subklewe, M, Thol, F, van de Loosdrecht, Aa, van der Reijden, Ba, Venditti, A, Wierzbowska, A, Valk, Pjm, Wood, Bl, Walter, Rb, Thiede, C, Döhner, K, Roboz, Gj, Cloos, J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3667::79de21a1db642f51cd6d9d8de04d4eef
http://hdl.handle.net/2108/281268
http://hdl.handle.net/2108/281268
Autor:
Beck, DB, Ferrada, MA, Sikora, KA, Ombrello, AK, Collins, JC, Pei, W, Balanda, N, Ross, DL, Ospina Cardona, D, Wu, Z, Patel, B, Manthiram, K, Groarke, EM, Gutierrez-Rodrigues, F, Hoffmann, P, Rosenzweig, S, Nakabo, S, Dillon, LW, Hourigan, CS, Tsai, WL, Gupta, S, Carmona-Rivera, C, Asmar, AJ, Xu, L, Oda, H, Goodspeed, W, Barron, KS, Nehrebecky, M, Jones, A, Laird, RS, Deuitch, N, Rowczenio, D, Rominger, E, Wells, KV, Lee, C-CR, Wang, W, Trick, M, Mullikin, J, Wigerblad, G, Brooks, S, Dell’Orso, S, Deng, Z, Chae, JJ, Dulau-Florea, A, Malicdan, MCV, Novacic, D, Colbert, RA, Kaplan, MJ, Gadina, M, Savic, S, Lachmann, HJ, Abu-Asab, M, Solomon, BD, Retterer, K, Gahl, WA, Burgess, SM, Aksentijevich, I, Young, NS, Calvo, KR, Werner, A, Kastner, DL, Grayson, PC
BACKGROUND Adult-onset inflammatory syndromes often manifest with overlapping clinical features. Variants in ubiquitin-related genes, previously implicated in autoinflammatory disease, may define new disorders. METHODS We analyzed peripheral-blood ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ed156b9e0d0cc322c720be3d2bca96f5
https://eprints.whiterose.ac.uk/167344/1/nejmoa2026834.pdf
https://eprints.whiterose.ac.uk/167344/1/nejmoa2026834.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hegde PS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Andrew G; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Gui G; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC, USA.; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Ravindra N; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Mukherjee D; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Wong ZC; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Auletta JJ; Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN, USA.; The Ohio State University College of Medicine, Columbus, OH, USA., El Chaer F; University of Virginia, Charlottesville, VA, USA., Corner A; Bio-Rad Laboratories, Pleasanton, CA, USA., Devine SM; Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN, USA., Jimenez Jimenez AM; Sylvester Comprehensive Cancer Center, Miami, FL, USA., De Lima MJG; The Ohio State University College of Medicine, Columbus, OH, USA., Litzow MR; Mayo Clinic, Rochester, MN, USA., Kebriaei P; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Saber W; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA., Spellman SR; Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN, USA., Zeger SL; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Page KM; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA., Dillon LW; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. laura.dillon2@nih.gov., Hourigan CS; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, DC, USA. hourigan@vt.edu.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2024 Oct 18. Date of Electronic Publication: 2024 Oct 18.
Autor:
Komrokji RS; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Lanino L; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Ball S; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Marchetti M; Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Maggioni G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Travaglino E; IRCCS Polilcinico San Matteo, Pavia, Italy., Al Ali NH; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Fenaux P; Saint Louis Hospital, Paris Cité University, Paris, France., Platzbecker U; University Hospital Leipzig, Leipzig, Germany., Santini V; University of Florence, Florence, Italy., Diez-Campelo M; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Singh A; Cleveland Clinic, Cleveland, OH, USA., Jain AG; Cleveland Clinic, Cleveland, OH, USA., Aguirre LE; Dana Farber Cancer Institute, Boston, MA, USA., Tinsley-Vance SM; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Schwabkey ZI; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Chan O; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Xie Z; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Brunner AM; Dana Farber Cancer Institute, Boston, MA, USA., Kuykendall AT; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Bennett JM; University of Rochester Medical Center, Rochester, NY, USA., Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Bejar R; University of California San Diego, San Diego, CA, USA., Carraway HE; Cleveland Clinic, Cleveland, OH, USA., DeZern AE; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Halene S; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Hasserjian RP; Massachusetts General Hospital, Boston, MA, USA., Lancet J; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., List AF; Precision BioSciences, Durham, NC, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Padron E; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Roboz GJ; New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA., Stahl M; Dana Farber Cancer Institute, Boston, MA, USA., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Steensma DP; Ajax Therapeutics, Cambridge, MA, USA., Savona MR; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Taylor J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Xu ML; Department of Pathology and Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA., Sweet K; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sallman DA; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Nimer SD; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Hourigan CS; Virginia Tech FBRI Cancer Research Center, Washington, DC, USA., Wei AH; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Sauta E; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., D'Amico S; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Train, Milan, Italy., Asti G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Castellani G; Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy., Delleani M; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Campagna A; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Borate UM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Sanz G; Instituto de Salud Carlos III, Valencia, Spain., Efficace F; Department of Haematology, La Fe University and Polytechnic Hospital, Valencia, Spain., Gore SD; Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA., Kim TK; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rozman M; Hospital Clínic Barcelona, Barcelona, Spain., Orfao A; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Foucar MK; University of New Mexico, Albuquerque, NM, USA., Germing U; Department of Haematology, Oncology, and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Scheinberg P; Beneficência Portuguesa de São Paulo Hospital, São Paulo, Brazil., Miyazaki Y; Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Iastrebner M; Sanatorio Sagrado Corazón, Buenos Aires, Argentina., Kulasekararaj A; King's College Hospital NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK., Cluzeau T; Nice University Hospital, Nice, France., Kordasti S; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College, London, UK., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, VU University Medical Center-Cancer Center, Amsterdam, Netherlands., Ades L; Saint Louis Hospital, Paris Cité University, Paris, France., Zeidan AM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Della Porta MG; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: matteo.della_porta@hunimed.eu.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.
Autor:
Aakash F; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gisriel SD; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA., Bennett JM; James P Wilmot Cancer Center and Division of Hematopathology, University of Rochester Medical Center, Rochester, NY, USA., Bejar R; Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, La Jolla, CA, USA., Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Borate UM; Division of Haematology, the Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Boultwood J; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Brunner AM; Division of Haematology, Massachusetts General Hospital Brigham, Boston, MA, USA., Buckstein R; Department of Medical Oncology/ Hematology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Carraway H; Leukemia Program, Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Churpek JE; Department of Haematology, Oncology, and Palliative Care, Carbone Cancer Center, The University of Wisconsin-Madison, Madison, WI., Daver NG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD, USA., Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Health Outcomes Research Unit, Rome, Italy., Fenaux P; Service d'hématologie, Hôpital Saint-Louis (Assistance Publique Hôpitaux de Paris) and Université de Paris-Cité, Paris, France., Figueroa ME; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gore SD; National Cancer Institute, Cancer Therapy Evaluation Program, Rockville, MD, USA., Greenberg PL; Division of Hematology, Department of Medicine, Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Halene S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA., Hourigan CS; Virginia Tech, Fralin Biomedical Research Institute, Cancer Research Center., Kim TK; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Kim N; NCI, NIH, Bethesda, Maryland., Komrokji RS; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Kutchroo V; Brigham and Women's Hospital, Boston, MA, USA., List AF; Precision BioSciences, Inc., Durham, NC, USA., Little RF; National Cancer Institute, Cancer Therapy Evaluation Program, Rockville, MD, USA., Majeti R; Division of Hematology, Department of Medicine, Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Nazha A; Department of Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Nimer SD; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Padron E; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Platzbecker U; Department of Haematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany., Della Porta MG; IRCCS Humanitas Research Hospital, Milan, Italy and Department of Biomedical Sciences, Humanitas University, Milan, Italy., Roboz GJ; Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY, USA., Sallman DA; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Santini V; Myelodysplastic syndromes Unit, Department of Experimental and Clinical Medicine, Haematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy., Sanz G; Health Research Institute La Fe, Valencia, Spain; Hospital Universitario y Politécnico La Fe, Valencia, Spain; CIBERONC, IS Carlos III, Madrid, Spain., Savona MR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Sekeres MA; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Stahl M; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Starczynowski DT; Cincinnati Children's Hospital, Cincinnati, OH., Steensma DP; David Steensma LLC, Cambridge, Massachusetts 02139, USA., Taylor J; Division of Haematology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA., Abdel-Wahab O; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wei AH; Department of Haematology, Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research and University of Melbourne, Victoria, Australia., Zhuoer X; Malignant Haematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Xu ML; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Hasserjian RP; Department of Pathology, Massachusetts General Hospital Brigham, Boston, MA, USA., Loghavi S; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: Sloghavi@mdanderson.org.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Sep 23, pp. 100615. Date of Electronic Publication: 2024 Sep 23.
Autor:
Trindade CJ; Laboratory of Pathology, NCI, NIH, Bethesda, Maryland, USA., Sun X; Department of Laboratory Medicine, CC, NIH, Bethesda, Maryland, USA., Maric D; Flow Cytometry Core Facility, NINDS, NIH, Bethesda, Maryland, USA., Sharma S; Department of Laboratory Medicine, CC, NIH, Bethesda, Maryland, USA., Komarow HD; Laboratory of Allergic Diseases, NIAID, NIH, Bethesda, Maryland, USA., Hourigan CS; Laboratory of Myeloid Malignancies, NHLBI, NIH, Bethesda, Maryland, USA., Klion A; Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, Maryland, USA., Maric I; Department of Laboratory Medicine, CC, NIH, Bethesda, Maryland, USA.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 Sep; Vol. 106 (5), pp. 370-382. Date of Electronic Publication: 2024 Apr 26.